政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/79418

English | 正體中文 | 简体中文 | Post-Print筆數 : 27 | Items with full text/Total items : 113656/144643 (79%)
Visitors : 51725635 Online Users : 623

RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.

Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer

政大機構典藏 > 理學院 > 應用物理研究所 > 期刊論文 > Item 140.119/79418

Please use this identifier to cite or link to this item: https://nccur.lib.nccu.edu.tw/handle/140.119/79418

Title:	Early treatment response predicted subsequent clinical response in patients with schizophrenia taking paliperidone extended-release
Authors:	Yeh, En-Chi;Huang, Ming-Chyi;Tsai, Chang-Jer;Chen, Chun-Tse;Chen, Kuan-Yu;Chiu, Chih-Chiang 蔡長哲
Contributors:	神科所
Keywords:	Antipsychotic;Dosing;Pharmacokinetics;Responder
Date:	2015-11
Issue Date:	2015-11-25 16:35:42 (UTC+8)
Abstract:	This 6-week open-labeled study investigated whether early treatment response in patients receiving paliperidone extended-release (paliperidone ER) can facilitate prediction of responses at Week 6. Patients with schizophrenia or schizoaffective disorder were administered 9 mg/day of paliperidone ER during the first 2 weeks, after which the dose was adjusted clinically. They were assessed on Days 0, 4, 7, 14, 28, and 42 by the Positive and Negative Syndrome Scale (PANSS). The serum concentrations of 9-hydroxyrisperidone were examined on Days 14 and 42. Among the 41 patients enrolled, 26 were classified as responders (≧50% improvement on total PANSS scores at Week 6). In the receiver-operator curves (ROC) analyses, the changes in total PANSS scores at Week 2 appeared to show more accurate predictability compared to Day 4 and Day 7. At Week 6, no significant correlation was observed between blood 9-hydroxyrisperidone concentration and the total score or changes of PANSS scores. The results suggest that early treatment response to paliperidone ER, particularly at Week 2, can serve as a suitable outcome predictor at Week 6. Using 9 mg/day paliperidone ER as an initial dose for schizophrenia treatment exhibited relatively favorable tolerability and feasibility.
Relation:	Psychiatry Research, 230(1), 13-18
Data Type:	article
DOI 連結:	http://dx.doi.org/10.1016/j.psychres.2015.07.037
DOI:	10.1016/j.psychres.2015.07.037
Appears in Collections:	[應用物理研究所 ] 期刊論文

Files in This Item:

File	Description	Size	Format
13-18.pdf		428Kb	Adobe PDF2	696	View/Open

社群 sharing

著作權政策宣告 Copyright Announcement

1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.

Loading...